N-(2-methoxyphenyl)-3-((4-nitrophenyl)thio)thiophene-2-carboxamide

ID: ALA4065637

PubChem CID: 60142736

Max Phase: Preclinical

Molecular Formula: C18H14N2O4S2

Molecular Weight: 386.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1NC(=O)c1sccc1Sc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C18H14N2O4S2/c1-24-15-5-3-2-4-14(15)19-18(21)17-16(10-11-25-17)26-13-8-6-12(7-9-13)20(22)23/h2-11H,1H3,(H,19,21)

Standard InChI Key:  AFAAPDYDCAFWPR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   16.7047   -7.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9574   -7.5575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4096   -6.9511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8182   -6.2420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6207   -6.4127    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.4138   -7.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4138   -8.4489    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1187   -7.2231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7908   -8.3559    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.0094   -8.6065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8428   -9.4090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0656   -9.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4550   -9.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6257   -8.3133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4029   -8.0627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6777   -9.3664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0457   -8.8513    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5501  -10.1724    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8278   -7.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5369   -7.2231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2419   -7.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2419   -8.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5369   -8.8575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8278   -8.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5369   -6.4059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2419   -5.9974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  1  5  1  0
  6  7  2  0
  6  8  1  0
  1  6  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 16 17  2  0
 16 18  1  0
 13 16  1  0
  9 10  1  0
  2  9  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 25 26  1  0
 20 25  1  0
  8 19  1  0
M  CHG  2  16   1  18  -1
M  END

Associated Targets(Human)

H9 (1832 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.45Molecular Weight (Monoisotopic): 386.0395AlogP: 5.07#Rotatable Bonds: 6
Polar Surface Area: 81.47Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.95CX LogD: 4.95
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -1.99

References

1. Zhou M, Luo RH, Hou XY, Wang RR, Yan GY, Chen H, Zhang RH, Shi JY, Zheng YT, Li R, Wei YQ..  (2017)  Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists.,  129  [PMID:28235704] [10.1016/j.ejmech.2017.01.010]

Source